Latest & greatest articles for menopause

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on menopause or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on menopause and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for menopause

221. Pathological complications of menopause. IPE-95/03 (Public report)

Pathological complications of menopause. IPE-95/03 (Public report) Pathological complications of menopause. IPE-95/03 (Public report) Pathological complications of menopause. IPE-95/03 (Public report) Sez A, Conde J, Ruiz F, Cuadrado C, Saiz J, Sancho J Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Sez A, Conde J, Ruiz F, Cuadrado C (...) , Saiz J, Sancho J. Pathological complications of menopause. IPE-95/03 (Public report) Agencia de Evaluacion de Tecnologias Sanitarias (AETS). 1995 Authors' objectives According to the recent Royal Decree (Real Decreto) which establishes the basic public coverage of health care, pathological complications of menopause must be specifically covered. The issue raised by the Ministry of Health is to establish the content of this definition and the necessity to find a specific build-up, procedures

1995 Health Technology Assessment (HTA) Database.

222. Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: a meta-analysis

Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: a meta-analysis Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: a meta-analysis Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: a meta-analysis Daya S, Gunby J, Hughes E G, Collins J A, Sagle M A Authors' objectives To conduct a systematic overview of available data comparing (...) follicle-stimulating hormone (FSH) with human menopausal gonadotropin (hMG) in in vitro fertilisation (IVF) cycles and gamete intra-fallopian transfer (GIFT) cycles. Searching MEDLINE was searched from 1975 to 1993 using MeSH terms (terms given). Bibliographies of relevant publications and review articles were scanned and abstracts of major scientific meetings from 1983 to 1993 were handsearched. Authors of relevant abstracts were contacted as were peer reviewers. Study selection Study designs of evaluations included

1995 DARE.

223. Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. (PubMed)

Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. 8136666 1994 04 25 1994 04 25 2016 11 23 0959-8138 308 6927 1994 Feb 19 BMJ (Clinical research ed.) BMJ Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. 501-3 To evaluate the efficacy of gamolenic acid provided by evening primrose oil in treating hot flushes and sweating associated with the menopause. Randomised, double blind, placebo controlled study. District general hospital (...) and teaching hospital. 56 menopausal women suffering hot flushes at least three times a day. Four capsules twice a day of 500 mg evening primrose oil with 10 mg natural vitamin E or 500 mg liquid paraffin for six months. Change in the number of hot flushes or sweating episodes a month. 56 diaries were analysed, 28 from women taking gamolenic acid and 28 from those taking placebo. Only 18 women given gamolenic acid and 17 given placebo completed the trial. The mean (SE) improvement in the number of flushes

Full Text available with Trip Pro

1994 BMJ

224. The efficacy and cost-effectiveness of adjuvant therapy of early breast cancer in pre-menopausal women

The efficacy and cost-effectiveness of adjuvant therapy of early breast cancer in pre-menopausal women The efficacy and cost-effectiveness of adjuvant therapy of early breast cancer in pre-menopausal women The efficacy and cost-effectiveness of adjuvant therapy of early breast cancer in pre-menopausal women Smith T J, Hillner B E Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary (...) of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Adjuvant tamoxifen with or without chemotherapy for early breast cancer in pre-menopausal women. Type of intervention Secondary prevention. Economic study type Cost-effectiveness and cost-utility analysis. Study population Women aged 45 years with early breast cancer, eligible for trials of alternative cancer treatments included in the review

1993 NHS Economic Evaluation Database.

225. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. (PubMed)

Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. 4047104 1985 10 30 1985 10 30 2013 11 21 0028-4793 313 16 1985 Oct 17 The New England journal of medicine N. Engl. J. Med. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. 973-5 To elucidate the effect of smoking on estrogen metabolism, we examined 136 postmenopausal women treated for one year with one of three different doses (...) Menopause Middle Aged Norethindrone analogs & derivatives therapeutic use Osteoporosis etiology Smoking 1985 10 17 1985 10 17 0 1 1985 10 17 0 0 ppublish 4047104 10.1056/NEJM198510173131602

1985 NEJM